About Us
Comprehensive Services
for the Pharmaceutical Market
Wide Range of Services and Commitment to Quality
At PHARMABELLE, our broad spectrum of services consistently addresses the needs of the pharmaceutical market and consumers, with an unwavering focus on high quality.
We provide comprehensive business development services, identifying and evaluating products while exploring opportunities in new markets.
Our technical support includes regulatory dossier management, contract manufacturing coordination, and product development.
We also manage the distribution of finished products—pharmaceutical, healthcare, and cosmetic—while offering advanced marketing and sales services.
By combining scientific expertise with an extensive sales network, we continuously support our pursuit of excellence.
Our Principles
At PHARMABELLE, contributing to the well-being and quality of life of the modern individual lies at the heart of our philosophy.
We offer high-quality, technologically advanced products designed to promote health and enhance everyday living.
PHARMABELLE places equal emphasis on its business activities.
We pursue strategic partnerships with high-standard suppliers and companies, aiming to deliver tangible added value both to our organization and to our partners.
Establishment and Development
PHARMABELLE stands out as a pioneer in the distribution of pharmaceutical and parapharmaceutical products in the Cypriot and international markets.
Founded in 2014 in Cyprus by the Tsetis Pharmaceutical Group of Companies (OFET), Pharmabelle has demonstrated continuous growth through collaborations with leading brands—such as those of the pharmaceutical manufacturers UNI-PHARMA and InterMed—reflecting our commitment to innovation and technological excellence.
The Group’s President and CEO, Julia Tsetis, Pharmacist MSc and Honorary Doctor of the National and Kapodistrian University of Athens and the University of Patras, underscores Cyprus’s pivotal role in the pharmaceutical sector, attributed to its rapid adoption of innovative health technologies and its position as a hub of outward-looking activity for companies operating within and beyond the European Union.
The Cypriot market—characterized by rapidly developing pharmaceutical activities and an expanding export orientation—serves as an important field for implementing innovation strategies and as a platform for entry into neighboring markets.
Commitment to Well-Being
& Business Integrity
